3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow 17 alpha-Hydroxyprogesterone Caproate: new trials by email Literature Review of 17 alpha-Hydroxyprogesterone Caproate trials Research Report on 17 alpha-Hydroxyprogesterone Caproate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) - Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women | Phase 1 | Completed | AMAG Pharmaceuticals, Inc. | 122 | 2016-09-01 | 2022-04-28 |
| Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood Hydroxyprogesterone caproate 250 mg/ml - Pregnancy | Phase 1 | Completed | Lumara Health, Inc. | 30 | 2013-07-01 | 2014-08-18 |
| Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial. 17-Hydroxyprogesterone Caproate, Caster Oil injections - Pregnancy Complications | Phase 1 / Phase 2 | Completed | Stanford University | 21 | 2010-02-01 | 2019-04-09 |
AMAG Pharmaceuticals, Inc. (1) · Lumara Health, Inc. (1) · Stanford University (1)
United States (3)
Julie Krop, MD (1) · Robert Birch, PhD (1) · Yasser Y El-Sayed, MD (1)